The Lancet Hiv

  • Citations Per Year
Learn More
For more on the Global Fund 2016 Replenishment Conference see http://www. theglobalfund.org/en/ replenishmentconference/; http://www.unaids.org/en/ resources/presscentre/ pressreleaseandstatement archive/2016/ september/20160920_GF_ statement; http://www. theglobalfund.org/en/ news/2016-09-16_Private_ Donors_Double_Investments_ to_the_Global_Fund/; and(More)
On October 6, Public Health England (PHE) updated their tables enumerating the scale of the HIV/AIDS epidemic in the UK with data to the end of 2013. The overall picture is heartening. The general decline in new HIV diagnoses since the high of 7892 in 2005 continued, with 6000 people being newly identifi ed as having the virus in 2013, the lowest number(More)
Shortly after this journal launched in 2014, the early termination of the PROUD study of pre-exposure prophylaxis (PrEP) with combined tenofovir disoproxil fumarate and emtricitabine raised hopes that the preventive approach would soon be made available. The UK study, done in men who have sex with men (MSM) who engage in high-risk sexual behaviour, showed a(More)
Scott County in southeastern Indiana, USA, would usually expect to record just fi ve new HIV infections a year, but in the past 4 months, 130 new diagnoses have been made in a localised outbreak. The sharp uptick in new cases has been linked to the sharing of needles used to inject the painkiller oxymorphone (Opana). Although, some of the newly identifi ed(More)
The latest UNAIDS statistics on HIV show that in the past 12 months an extra 2 million people have accessed HIV treatment: 17 million of the near 37 million infected are now receiving potentially life-saving antiretroviral drugs. As the proportion of people on treatment moves closer to 50%, the benefi cial eff ects are already moving beyond viral(More)